TCEAL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.345800E-01
Normal-vs-Stage2
1.546020E-01
Normal-vs-Stage3
2.631000E-01
Normal-vs-Stage4
7.573000E-01
Stage1-vs-Stage2
1.153380E-01
Stage1-vs-Stage3
2.730600E-01
Stage1-vs-Stage4
9.108600E-01
Stage2-vs-Stage3
5.741000E-01
Stage2-vs-Stage4
2.585200E-01
Stage3-vs-Stage4
3.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.778600E-01
Normal-vs-AfricanAmerican
4.911200E-01
Normal-vs-Asian
6.557900E-02
Caucasian-vs-AfricanAmerican
7.364800E-01
Caucasian-vs-Asian
2.027200E-01
AfricanAmerican-vs-Asian
1.652560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.274400E-01
Normal-vs-Female
3.869200E-01
Male-vs-Female
6.820000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.356400E-01
Normal-vs-Age(41-60Yrs)
4.975600E-01
Normal-vs-Age(61-80Yrs)
3.206000E-01
Normal-vs-Age(81-100Yrs)
5.193900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.993400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.413000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.105400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.636380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.315600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.579500E-02
Normal-vs-Daily Drinker
2.428000E-01
Normal-vs-Weekly Drinker
1.095020E-01
Normal-vs-Occasional Drinker
6.490000E-01
Normal-vs-Social Drinker
6.187800E-01
Non Drinker-vs-Daily Drinker
3.708600E-01
Non Drinker-vs-Weekly Drinker
8.431600E-01
Non Drinker-vs-Occasional Drinker
1.346560E-01
Non Drinker-vs-Social Drinker
1.677010E-01
Daily Drinker-vs-Weekly Drinker
5.863600E-01
Daily Drinker-vs-Occasional Drinker
3.866400E-01
Daily Drinker-vs-Social Drinker
4.231200E-01
Weekly Drinker-vs-Occasional Drinker
2.396400E-01
Weekly Drinker-vs-Social Drinker
2.543600E-01
Occasional Drinker-vs-Social Drinker
9.643400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.145400E-01
Normal-vs-Grade 2
8.073500E-02
Normal-vs-Grade 3
9.324500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.486600E-01
Grade 1-vs-Grade 3
9.808100E-02
Grade 1-vs-Grade 4
2.145400E-01
Grade 2-vs-Grade 3
2.602600E-01
Grade 2-vs-Grade 4
8.073500E-02
Grade 3-vs-Grade 4
9.324500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.012200E-02
Normal-vs-NonDiabetic
3.704600E-01
Diabetic-vs-NonDiabetic
6.740100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.265420E-01
Normal-vs-NoPancreatitis
3.032600E-01
Pancreatitis-vs-NoPancreatitis
3.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.807600E-01
Normal-vs-N1
1.857980E-01
N0-vs-N1
3.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.462010E-01
Normal-vs-TP53-NonMutant
8.936400E-01
TP53-Mutant-vs-TP53-NonMutant
1.497230E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
